1 Min Read
Jan 30 (Reuters) - Mapi Pharma Ltd:
* FIRST PATIENT TREATED IN MAPI PHARMA’S PHASE II CLINICAL TRIAL OF GA DEPOT FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.